THE IMMUNOVERSE Trademark

Trademark Overview

On Tuesday, May 7, 2024, a trademark application was filed for THE IMMUNOVERSE with the United States Patent and Trademark Office. The USPTO has given the THE IMMUNOVERSE trademark a serial number of 98537589. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, January 5, 2026. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The THE IMMUNOVERSE trademark is filed in the Education & Entertainment Services category with the following description:

Entertainment services, namely, providing podcasts in the field of immunotherapy
the immunoverse

General Information

Serial Number98537589
Word MarkTHE IMMUNOVERSE
Filing DateTuesday, May 7, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, January 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Pseudo MarkTHE IMMUNO VERSE
Goods and ServicesEntertainment services, namely, providing podcasts in the field of immunotherapy

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, May 7, 2024
Primary Code041
First Use Anywhere DateThursday, April 24, 2025
First Use In Commerce DateThursday, April 24, 2025

Trademark Owner History

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33612
Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Trademark Events

Event DateEvent Description
Tuesday, May 7, 2024NEW APPLICATION ENTERED
Monday, November 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 6, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 7, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, June 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 11, 2025SOU TEAS EXTENSION RECEIVED
Monday, December 15, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 11, 2025SOU EXTENSION 1 FILED
Tuesday, December 16, 2025SOU EXTENSION 1 GRANTED
Wednesday, May 7, 2025USE AMENDMENT FILED
Tuesday, December 16, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 16, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 5, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 5, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

immunoverse field immunotherapy podcasts providing services namely entertainment